共 50 条
- [21] Drug-Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (11): : 1253 - 1263
- [24] Effect of aprepitant, a moderate CYP3A4 inhibitor, on bosutinib exposure in healthy subjects European Journal of Clinical Pharmacology, 2017, 73 : 49 - 56
- [26] Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects European Journal of Clinical Pharmacology, 2020, 76 : 1125 - 1133